Sirnaomics Ltd. (HK:2257) has released an update.
Sirnaomics Ltd., a company focused on advancing RNAi therapeutics, has announced a further delay in the dispatch of its circular containing details of its patent assignment and subscription agreements. Initially expected by November 29, 2024, the company now anticipates sending the circular by December 31, 2024. This delay is due to the additional time needed to prepare and finalize necessary information for shareholders.
For further insights into HK:2257 stock, check out TipRanks’ Stock Analysis page.
